ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "anti-TNF therapy and remission"

  • Abstract Number: 2906 • 2019 ACR/ARP Annual Meeting

    DMARD-free Remission in Established Rheumatoid Arthritis: 2 Year Results of the TARA Trial

    Elise van Mulligen1, Angelique Weel 2, Martijn Kuijper 2, Mieke Hazes 1, Annette van der Helm-van Mil 3 and Pascal de Jong 1, 1Erasmus MC, Rotterdam, Netherlands, 2Maasstad Hospital, Rotterdam, Netherlands, 3LUMC, Leiden, Zuid-Holland, Netherlands

    Background/Purpose: In rheumatoid arthritis (RA) disease outcomes  have improved enormously in the last  decades. Due to early initiation of therapy, a treat-to-target approach and a…
  • Abstract Number: 2744 • 2017 ACR/ARHP Annual Meeting

    Long-Term Remission in Severe Behcet’s Disease Following Withdrawal of Successful Anti-TNF Treatment

    Petros P Sfikakis1, Aikaterini Arida1, Stylianos Panopoulos2, Kalliopi Fragkiadaki2, George Pentazos3, Katerina Laskari3, Maria Tektonidou1 and Nikos Markomichelakis2, 1First Department of Propaedeutic and Internal Medicine and Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, athens, Greece, 2First Department of Propaedeutic and Internal Medicine and Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, Athens, Greece, 3Rheumatology Unit, 1st Dept. of Propaedeutic Internal Medicine, Joined Academic Rheumatology Program, Athens University Medical School, Athens, Greece

    Background/Purpose: Anti-TNF treatment has been shown to be effective in inducing complete remission in many Behcet’s disease (BD) patients with eye, large vessel, intestine and…
  • Abstract Number: 608 • 2016 ACR/ARHP Annual Meeting

    Initial Intensive Therapy of Adalimumab and Methotrexate Is Associated with Long-Term Structural Remission and Low Disease Activity after Adalimumab Discontinuation Is Maintained up to 3 Years in Japanese Patients: Hopeful-3 Study

    Yoshiya Tanaka1, Hisashi Yamanaka2, Naoki Ishiguro3, Nobuyuki Miyasaka4, Katsuyoshi Kawana5, Naoki Agata5 and Tsutomu Takeuchi6, 1University of Occupational and Environmental Health, Kitakyushu, Japan, 2Tokyo Women's Medical University, Tokyo, Japan, 3Department of Orthopedic Surgery, Nagoya University, Graduate School & Faculty of Medicine, Nagoya, Japan, 4Tokyo Medical and Dental University, Tokyo, Japan, 5Abbvie GK, Tokyo, Japan, 6Division of Rheumatology, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose:   Methods:   Of 172 patients enrolled, 135 (ADA continuation, n=61; ADA discontinuation, n=74) with DAS28–CRP at both week 52 (start of HOPEFUL-2) and week 208…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.